Amendia announced the commercial launch of the Ceres™ Midline Cervical Plate, intended for anterior screw fixation of the cervical spine (C2-C7) as an adjunct to fusion. The system is indicated for degenerative disc disease, spondylolisthesis, trauma, spinal stenosis, deformity, tumor, pseudarthrosis or failed previous fusion.
The Ceres Midline Cervical Plate has a width of 10.5mm and low profile 2.3mm, is designed for one and two-level surgeries and is available in 18 different length sizes.
This marks Amendia’s fourth product launch in 2016. Earlier this month, the company launched the Ceres™-C Standalone Cervical Interbody Device. In 1Q16, the company launched the inCORPorate™ PEEK Vertebral Body Replacement and the OmegaLIF™ Expandable Interbody Cage.
Earlier this quarter, a majority ownership of Amendia was acquired by private equity firm Kohlberg & Company.
Amendia announced the commercial launch of the Ceres™ Midline Cervical Plate, intended for anterior screw fixation of the cervical spine (C2-C7) as an adjunct to fusion. The system is indicated for degenerative disc disease, spondylolisthesis, trauma, spinal stenosis, deformity, tumor, pseudarthrosis or failed previous fusion.
The Ceres...
Amendia announced the commercial launch of the Ceres™ Midline Cervical Plate, intended for anterior screw fixation of the cervical spine (C2-C7) as an adjunct to fusion. The system is indicated for degenerative disc disease, spondylolisthesis, trauma, spinal stenosis, deformity, tumor, pseudarthrosis or failed previous fusion.
The Ceres Midline Cervical Plate has a width of 10.5mm and low profile 2.3mm, is designed for one and two-level surgeries and is available in 18 different length sizes.
This marks Amendia’s fourth product launch in 2016. Earlier this month, the company launched the Ceres™-C Standalone Cervical Interbody Device. In 1Q16, the company launched the inCORPorate™ PEEK Vertebral Body Replacement and the OmegaLIF™ Expandable Interbody Cage.
Earlier this quarter, a majority ownership of Amendia was acquired by private equity firm Kohlberg & Company.
Copy to clipboard 
